"如果选择自费进行CAR—T细胞疗法，将付出掏空家庭所有积蓄的代价。"面对昂贵的治疗费用，不久 前被诊断癌症的刘先生相当惆怅。 刘先生直言，若自己选择CAR—T细胞疗法，单次治疗费用超过百万元，自己实在不愿因此令整个家庭 变得拮据。 如何不让昂贵的创新药治疗费用"阻碍"病人就诊，正成为社会日益关注的一大热门话题。 北京中健联健康服务促进中心副会长濮亮向记者表示，创新药的广泛应用亟需可持续、高效率的支付体 系支撑。 为了推动创新药发展与解决创新药可及性问题，近年国家出台一系列政策，包括支持创新药进入基本医 保目录与商业健康保险创新药品目录（下称"商保创新药目录"），持续提高创新药多元支付能力，力图 打通创新药的"最后一公里"。 随着中国老龄化社会来临与民众治疗需求日益加大，中国已跃居全球第二大药品支出市场，年均复合增 长率超过3%。其中，创新药成为市场增长的主要驱动力。 数据显示，去年中国创新药市场规模达到约1620亿元，同比增长16%。与此对应的是，全球创新药在中 国首发的趋势持续增强，2017年仅有9%新药在中国首发上市，2023年这个数值上升至29%。 但是，光靠基本医保难以全面覆盖所有创新药物的医疗支出 ...

Group 1 - The core viewpoint emphasizes the ongoing reforms and opening-up initiatives in Shanghai, particularly in the Pudong New Area, aimed at enhancing its role as a leading area for modern socialist construction and high-level institutional opening-up [2][4]. - The Shanghai International Business Cooperation Zone is under construction, expected to become one of the most open regions internationally [1]. - The Shanghai Auto Show in 2025 attracted nearly 1,000 renowned enterprises from 26 countries and regions, showcasing over a hundred new models, reflecting confidence in China's vast market and development [1]. Group 2 - The "One Industry, One License" reform has significantly streamlined the process for businesses, reducing the time to open a store from over 20 days to just a few hours, allowing a coffee chain to open 130 new stores in a year [3]. - The establishment of a joint regulatory mechanism for special biomedical items in Shanghai has facilitated the first cross-border transport and use of CAR-T cell therapy in the country, demonstrating the effectiveness of policy innovation [4]. - Shanghai has developed 23 local regulations and 34 management measures to support market entities and enhance the legal framework for business operations, contributing to a more favorable business environment [6].